Although NC410 is an effective LAIR-1 antagonist in vitro [3] and is present to a high extent at the tumour site in vivo [4], it is not yet clear whether NC410 only functions by blocking LAIR-1:collagen interactions. This evidence concerns the gene LAIR1 and neoplasm.